Stress management skills, neuroimmune processes and fatigue levels in persons with chronic fatigue syndrome

Brain, Behavior, and Immunity

Volumn 26, Issue 6, 2012, Pages 849-858

  Lattie, Emily G ^a   Antoni, Michael H ^a   Fletcher, Mary Ann ^b   Penedo, Frank ^a,b   Czaja, Sara ^b   Lopez, Corina ^a   Perdomo, Dolores ^b   Sala, Andreina ^b   Nair, Sankaran ^b   Fu, Shih Hua ^b   Klimas, Nancy ^b  

^a University of Miami   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic fatigue syndrome; Immune dysfunction; Stress management

Indexed keywords

HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; CHRONIC FATIGUE SYNDROME; CYTOKINE PRODUCTION; EMOTIONAL STRESS; FATIGUE; FEMALE; HUMAN; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; NEUROIMMUNOLOGY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REVIEW; SALIVA LEVEL; SELF REPORT; SKILL; STRESS MANAGEMENT;

ADULT; AGED; CYTOKINES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EDUCATIONAL STATUS; EMPLOYMENT; ETHNIC GROUPS; FATIGUE; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; NEUROIMMUNOMODULATION; SALIVA; SICK ROLE; SOCIAL ENVIRONMENT; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84863874496     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.02.008     Document Type: Review

References (97)

1. Addington J.W. Chronic fatigue syndrome: a dysfunction of the hypothalamic-pituitary-adrenal axis. J. Chron. Fatigue Synd. 2000, 7(2):63-73.
2. Alesci S., Martinez P.E., Kelkar S., Ilias I., Ronsaville D.S., Listwak S.J., Ayala A.R., Licinio J., Gold H.K., Kling M.A., Chrousos G.P., Gold P.W. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J. Clin. Endocrinol. Metab. 2005, 90:2522-2530.
3. Al-Harthi L., Wright D.J., Anderson D., Cohen M., Matity, Ahu D., Cohn J., Cu-Unvin S., Burns D., Reichelderfer P., Lewis S., Beckner S., Kovacs A., Landay A. The impact of the ovulatory cycle on cytokine production: evaluation of systemic, cervicovaginal, and salivary compartments. J. Interferon Cytokine Res. 2000, 20:719-724.
4. Antoni, M.H., in press. Stress management, psychoneuroimmunology and disease. In: Segerstrom, S. (Ed.), Psychoneuroimmunology, Oxford, NY, pp. 1121-1228.
5. Antoni M.H., Weiss D. Stress, immunity, and chronic fatigue syndrome: a conceptual model to guide the development of treatment and research. Handbook of Chronic Fatigue Syndrome and Fatiguing Illnesses 2003, Wiley, New York. L.A. Jason, P.A. Fennell, R.R. Taylor (Eds.).
6. Antoni M.H., Brickman A., Lutgendorf S., Klimas N., Imia-Fins A., Ironson G., Quillan R., Miguez M.J., van Riel F., Morgan R., Patarca R., Fletcher M.A. Psychosocial correlates of illness burden in Chronic Fatigue Syndrome. Clin. Infect. Dis. 1994, 18(Suppl. 1):S73-S78.
7. Antoni M.H., Carrico A.W., Duran R.E., Spitzer S., Penedo F., Ironson G., Fletcher M.A., Klimas N., Schneiderman N. Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in. Psychosom. Med. 2006, 68:143-151.
8. Antoni M.H., Lechner S.C., Kazi A., Wimberly S.R., Sifre T., Urcuyo K.R., Phillips K., Gluck S., Carver C.S. How stress management improves quality of life after treatment for breast cancer. J. Consult. Clin. Psychol. 2006, 74:1143-1152.
9. Antoni M.H., Lechner S., Diaz A., Vargas S., Holley H., Phillips K., McGregor B.A., Carver C.S., Blomberg B. Cognitive behavioral stress management effects on psychosocial and physiological adaptation in women undergoing treatment for breast cancer. Brain Behav. Immun. 2009, 23:580-591.
10. Bansal A.S., Bradley A.S., Bishop K.N., Kiani-Alikhan S., Ford B. Chronic fatigue syndrome, the immune system and viral infection. Brain Behav. Immun. 2012, 26:24-31.
11. Bollinger T., Bollinger A., Naujoks J., Lange T., Solbach W. The influence of regulatory T cells and diurnal hormone rhythms on T helper cell activity. Immunology 2010, 131:488-500.
12. Bonda T., Kaminski K.A., Kozuch M., Kozieraszka A., Wojtkowska I., Dobrzycki S., Kralisz P., Nowak K., Prokopczuk P., Musial W.J. Circadian variations of interleukin 6 in coronary circulations of patients with myocardial infarction. Cytokine 2010, 50:204-209.
13. Borish L., Schmaling K., DiClementi J.D., Streib J., Negri J., Jones J.F. Chronic fatigue syndrome: identification of distinct subgroups on the basis of allergy and psychologic variables. J. Allergy Clin. Immunol. 1998, 102(2):222-230.
14. Bower J.E., Ganz P.A., Aziz N., Olmstead R., Irwin M.R., Cole S.W. Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids. Brain Behav. Immun. 2007, 21(3):251-258.
15. Brenu E.W., van Driel M.L., Staines D.R., Ashton K.J., Ramos S.B., Keane J., Klimas N.G., Marshall-Gradisnik S.M. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J. Transl. Med. 2011, 9:81.
16. Broderick G., Fuite J., Kreitz A., Vernon S.D., Klimas N., Fletcher M.A. A formal analysis of cytokine networks in Chronic Fatigue Syndrome. Brain Behav. Immun. 2010, 24:1209-1217.
17. Carlo-Stella N., Badulli C., De Silvestri A., Bazzichi L., Martinetti M., Lorusso L., Bombardieri S., Salvaneschi L., Cuccia M. A first study of cytokine genomic polymorphisms in CFS: positive association of TNF-857 and IFNgamma 874 rare alleles. Clin. Exp. Rheumatol. 2006, 24(2):179-182.
18. Carruthers B.M., van de Sande M.I., De Meirleir K.L., Klimas N.G., Broderick G., Mitchell T., Staines D., Powles A.C.P., Speight N., Vallings R., Bateman L., Baumgarten-Austrheim B., Bell D.S., Carlo-Stella N., Chia J., Darragh A., Jo D., Lewis D., Light A.R., Marshall-Gradisbik S., Mena I., Mikovits J.A., Miwa K., Murovska M., Pall M.L., Stevens S. Myalgic encephalomyelitis: international consensus criteria. J. Intern. Med. 2011, 4:327-338.
19. Carver, C.S., 2006. Measure of Current Status. <>. http://www.psy.miami.edu/faculty/ccarver/sclMOCS.html.
20. Chiswick E.L., Duffy E., Japp B., Remick D. Detection and quantification of cytokines and other biomarkers. Methods Mol. Biol. 2012, 844:15-30.
21. Cohen S., Kamarck T., Mermelstein R. A global measure of perceived stress. J. Health Soc. Behav. 1983, 24:385-396.
22. Collado-Hidalgo A., Bower J.E., Ganz P.A., Cole S.W., Irwin M.R. Inflammatory biomarkers of persistent fatigue in breast cancer. Clin. Cancer Res. 2006, 12(9):2759-2766.
23. Corradi K.M., Jason L.A., Torres-Harding S.R. Exploratory subgrouping in CFS: infectious, inflammatory, and other. Adv. Psychol. Res. 2006, vol. 41:115-127. Nova Science Publishers, Hauppauge, NY.
24. Cruess D.G., Antoni M.H., McGregor B.A., Boyers A., Kumar M., Kilbourn K. Cognitive-behavioral stress management reduces serum cortisol by enhancing positive contributions among women being treated for early stage breast cancer. Psychosom. Med. 2000, 62:304-308.
25. Dantzer R., Kelley K.W. Twenty years of research on cytokine-induced sickness behavior. Brain Behav. Immun. 2007, 21:153-160.
26. Davis M.C., Zautra A.J., Younger J., Motivala S.J., Attrep J., Irwin M.R. Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: implications for fatigue. Brain Behav. Immun. 2008, 22:24-32.
27. Demitrack M., Crofford L. Evidence for and pathophysiological implications of hypothalamic pituitary adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Ann. N. Y. Acad. Sci. 1998, 840:684-697.
28. Faul L.A., Jim H.S., Williams C., Loftus L., Jacobsen P.B. Relationship of stress management skill to psychological distress and quality of life in adults with cancer. Psychooncology 2010, 19:102-109.
29. Faulkner S., Smith A. A longitudinal study of the relationship between psychological distress and recurrence of upper respiratory tract infections in chronic fatigue syndrome. Br. J. Health Psychol. 2008, 13(1):177-186.
30. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I/NP): Biometrics 2002, Research, New York State Psychiatric Institute, New York.
31. Fletcher M.A., Zeng X.R., Barnes Z., Levis S., Klimas N.G. Plasma cytokines in women with chronic fatigue syndrome. J. Transl. Med. 2009, 7:96.
32. Fletcher M.A., Rosenthal M., Antoni M., Ironson G., Zeng X.R., Barnes Z., Harvey J.M., Hurwitz B., Levis S., Broderick G., Klimas N.G. Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome. Behavioral and Brain Functions 2010, 6:76.
33. Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The Chronic Fatigue Syndrome: a comprehensive approach to its definition and study. Ann. Intern. Med. 1994, 121(12):953-959. International Chronic Fatigue Syndrome Study Group.
34. Gaab J., Engert V., Heitz V., Schad T., Schürmeyer T.H., Ehlert U. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in Chronic Fatigue Syndrome. J. Psychosom. Res. 2004, 56(4):419-424.
35. Gaab J., Rohleder N., Heitz V., Engert V., Schad T., Schürmeyer T.H., Ehlert U. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome. Psychoneuroendocrinology 2005, 30:188-198.
36. Glaser R., Kiecolt-Glaser J.K. Stress-associated immune modulation: relevance to viral infections and chronic fatigue syndrome. Am. J. Med. 1998, 105(3):35S-42S.
37. Haack M., Kraus T., Schuld A., Dalal M., Koethe D., Pollmächer T. Diurnal variations of interleukin-6 plasma levels are confounded by blood drawing procedures. Psychoneuroendocrinology 2002, 27:921-931.
38. Hann D.M., Jacobsen P.B., Azzarello L.M., Martin S.C., Curran S.L., Fields K.K., Greenberg H., Lyman G. Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual. Life Res. 1998, 7:301-310.
39. Heim C., Ehlert U., Hellhammer D.H. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 1999, 25:1-35.
40. Heim C., Nater U.M., Maloney E., Boneva R., Jones J.F., Reeves W.C. Childhood trauma and risk for chronic fatigue syndrome: association with neuroendocrine dysfunction. Arch. Gen. Psychiatry 2009, 66:72-80.
41. Hickie I., Lloyd A., Hadzi-Pavlovic D., Parker G., Bird K., Wakefield D. Can the chronic fatigue syndrome by defined by distinct clinical features?. Psychol. Med. 1995, 25:925-935.
42. Himmerich H., Fulda S., Linseisen J., Seiler H., Wolfram G., Himmerich S., Gedrich K., Pollmacher T. TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population. Eur. Cytokine Netw. 2006, 17:196-201.
43. Jason L.A., Richman J.A., Rademaker A.W., Jordan K.M., Plioplys A.V., Taylor R.R., McCready W., Huang C.F., Plioplys S. A community-based study of Chronic Fatigue Syndrome. Arch. Intern. Med. 1999, 159:2129-2137.
44. Jason L.A., Torres-Harding S.R., Jurgens A., Helgerson J. Comparing the Fukuda et al. criteria and the Canadian case definition for Chronic Fatigue Syndrome. J. Chron. Fatigue Synd. 2004, 12(1):37-52.
45. Jason L.A., Torres-Harding S.R., Friedberg F., Corradi K., Njoku M.G., Donalek J., Reynolds N., Brown M., Weitner B.B., Rademaker A. Non-pharmacologic interventions for CFS: a randomized trial. J. Clin. Psychol. Med. Settings 2007, 14:275-296.
46. Jerjes W.K., Cleare A.J., Wessely S., Wood P.J., Taylor N.F. Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome. J. Affect. Disord. 2005, 87:299-304.
47. Kelley K.W., Bluthe R.M., Dantzer R., Zhou J.H., Shen W.H., Johnson R.W., Broussard S.R. Cytokine-induced sickness behavior. Brain Behav. Immun. 2003, 17:S112-118.
48. Klimas N.G., Koneru A.O. Chronic fatigue syndrome: inflammation, immune function, and neuroendocrine interactions. Curr. Rheumatol. Rep. 2007, 9(6):482-487.
49. Patients' power and PACE. The Lancet 2011, 377:1808. Lancet.
50. Lombardi V.C., Ruscetti F.W., Gupta J.D., Pfost M.A., Hagen K.S., Peterson D.L., Ruscetti S.K., Bagni R.K., Petro-Sadowski C., Gold B., Dean M., Silverman R.H., Mikovits J.A. Detection of an infectious retrovirus, XMRV, in the blood cells of patients with Chronic Fatigue Syndrome. Science 2009, 326(5952):585-589.
51. Lopez C., Antoni M., Penedo F., Weiss D., Cruess S., Segotas M.C., Helder L., Siegel S., Klimas N., Fletcher M.A. A pilot study of cognitive behavioral stress management effects on stress, quality of life, and symptoms in persons with chronic fatigue syndrome. J. Psychosom. Res. 2011, 70(4):328-334.
52. Lorusso L., Mikhaylova S.V., Capelli E., Ferrari D., Ngonga G.K., Ricevuti G. Immunological aspects of chronic fatigue syndrome. Autoimmun. Rev. 2009, 8(4):287-291.
53. Lutgendorf S.K., Antoni M.H., Fletcher M.A., Penedo F., Baum A., Schneiderman N., Klimas N. Physical symptoms of chronic fatigue syndrome are exacerbated by the stress of Hurricane Andrew. Psychosom. Med. 1995, 57(4):310-323.
54. Lutgendorf S.K., Garand L., Buckwalter K.C., Reimer T.T., Hong S.Y., Lubaroff D.M. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J. Gerontol. 1999, 54:M434-439.
55. Maes M., Song C., Lin C., De Jongh R., Van Gastel A., Kenis G., Bosmans E., De Meester I., Benoy I., Neels H., Demedts P., Janca A., Scharpe S., Smith R.S. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and Th1-like response in stress-induced anxiety. Cytokine 1998, 10(4):313-318.
56. McGregor B.A., Antoni M.H., Boyers A., Alferi S.M., Blomberg B.B., Carver C.S. Cognitive-behavioral stress management increases benefit finding and immune function among women with early-stage breast cancer. J. Psychosom. Res. 2004, 56:1-8.
57. McNair D., Lorr M., Droppelman L.F. Manual: Profile of Mood States 1971, Educational and Industry Testing Service (EDITS), San Diego, CA.
58. Moss R.B., Merchandetti A., Vojdani A. TNF-a and chronic fatigue syndrome. J. Clin. Immunol. 1999, 19:314-316.
59. Nas K., Cevik R., Batum S., Sarac A.J., Acar S., Kalkanli S. Immunologic and psychosocial status in Chronic Fatigue Syndrome. Bratislava Med. J. 2011, 112(4):208-212.
60. Nater U.M., Youngblood L.S., Jones J.F., Unger E.R., Miller A.H., Reeves W.C., Heim C. Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with Chronic Fatigue Syndrome. Psychosom. Med. 2008, 70(3):298-305.
61. Njoku M.G., Jason L.A., Torres-Harding The prevalence of chronic fatigue syndrome in Nigeria. J. Health Psychol. 2007, 12(3):461-474.
62. O'Brien S.M., Fitzgerald P., Scully P., Landers A., Scott L.V., Dinan T.G. Impact of gender and menstrual cycle phase on plasma cytokine concentrations. NeuroImmunoModulation 2007, 14:84-90.
63. O'Connor M.F., Bower J.E., Cho H.J., Creswell J.D., Dimitrov S., Hamby M.E., Hoyt M.A., Martin J.L., Robles T.F., Sloan E.K., Thomas K.S., Irwin M.R. To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers. Brain Behav. Immun. 2009, 23:887-897.
64. Panagiotakos D.B., Pitsavos C., Yannakoulia M., Crysohoou C., Stefanadis C. The implication of obesity and central fat on markers of chronic inflammation: the ATTICA study. Atherosclerosis 2005, 183:308-315.
65. Patarca R., Klimas N.G., Lutgendorf S., Antoni M., Fletcher M.A. Dysregulated expression of tumor necrosis factor in Chronic Fatigue Syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression. Clin. Infect. Dis. 1994, 18:S147-S153.
66. Penedo F.J., Dahn J.R., Molton I., Gonzalez J.S., Roos B.A., Carver C.S., Schneiderman N., Antoni M. Cognitive-behavioral stress management improves stress-management skills and quality of life in men recovering from treatment of prostate carcinoma. Cancer 2004, 100(1):192-200.
67. Penedo F.J., Molton I., Dahn J.R., Shen B.J., Kinsinger D., Traeger L., Siegel S., Schneiderman N., Antoni M. A randomized clinical trial of group-based cognitive-behavioral stress management in localized prostate cancer: development of stress management skills improves quality of life and benefit finding. Ann. Behav. Med. 2006, 31(3):261-270.
68. Penedo F.J., Traeger L., Dahn J.R., Molton I., Gonzalez J.S., Schneiderman N., Antoni M. Cognitive behavioral stress management intervention improves quality of life in Spanish monolingual Hispanic men treated for localized prostate cancer: results of a randomized control trial. Int. J. Behav. Med. 2007, 14(3):164-172.
69. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J. Am. Geriatr. Soc. 1975, 23(10):433-441.
70. Porter N., Lerch A., Jason L.A., Sorenson M., Fletcher M.A., Herrington J. A comparison of immune functionality in viral versus non-viral CFS subtypes. J. Behav. Neurosci. Res. 2010, 8(2):1-8.
71. Preacher K.J., Hayes A.F. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav. Res. Methods 2008, 40(3):879-891.
72. Preacher K.J., Rucker D.D., Hayes A.F. Addressing moderated mediation hypotheses: Theory, methods, and prescriptions. Multivar. Behav. Res. 2007, 42(1):185-227.
73. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1977, 1(3):385-401.
74. Reeves W.C., Wagner D., Nisenbaum R., Jones J.F., Gurbaxani B., Solomon L., Papanicolaou D.A., Unger E.R., Vernon S.D., Heim C. Chronic fatigue syndrome - a clinically empirical approach to its definition and study. BMC Med. 2005, 3(19).
75. Reyes M., Nisenbaum R., Hoaglin D.C., Unger E.R., Emmons C., Randall B., Stewart J.A., Abbey S., Jones J.F., Gantz N., Minden S., Reeves W.C. Prevalence and incidence of Chronic Fatigue Syndrome in Wichita, Kansas. Arch. Intern. Med. 2003, 163:1530-1536.
76. Roberts A.D.L., Wessely S., Chalder T., Papadopoulos A., Cleare A.J. Salivary cortisol response to awakening in chronic fatigue syndrome. Br. J. Psychiatry 2004, 184:135-141.
77. Rosmond R., Dallman M.F., Björntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic, and hemodynamic abnormalities. J. Clin. Endocrinol. Metab. 1998, 86(6):1853-1859.
78. Rubin G.J., Hotopf M., Papadopoulos A., Cleare A. Salivary cortisol as a predictor of postoperative fatigue. Psychosom. Med. 2005, 67(3):441-447.
79. Sephton S.E., Sapolsky R.M., Kraemer H.C., Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J. Natl. Cancer Inst. 2000, 92:994-1000.
80. Servaes P., van der Werf S., Prins J., Verhagen S., Bleijenberg G. Fatigue in disease-free cancer patients compared with fatigue in patients with Chronic Fatigue Syndrome. Support. Care Cancer 2000, 9:11-17.
81. Servaes P., Prins J., Verhagen S., Bleigenberg G. Fatigue after breast cancer and in chronic fatigue syndrome: similarities and differences. J. Psychosom. Res. 2002, 52(6):453-459.
82. Siegel S., Antoni M.H., Fletcher M.A., Maher K., Segota M.C., Klimas N. Impaired natural Immunity, cognitive dysfunction, and physical symptoms in patients with Chronic Fatigue Syndrome: preliminary evidence for a subgroup?. J. Psychosom. Res. 2006, 60:559-566.
83. Smith K.A. Interleukin-2: inception, impact, and implications. Science 1988, 240(4856):1169-1176.
84. Steptoe A., Willemsen G., Owen N., Flower L., Mohamed-Ali V. Acute mental stress elicits delayed increases in circulating inflammatory cytokine levels. Clin. Sci. 2001, 101:185-192.
85. Stone A.A., Schwartz J.E., Smyth J., Kirshbaum C., Cohen S., Hellhammer D., Grossman S. Individual differences in the diurnal cycle of salivary free cortisol: a replication of flattened cycles for some individuals. Psychoneuroendocrinology 2001, 26:295-306.
86. ter Wolbeek M., van Doornen L.J., Coffeng L.E., Kavelaars A., Heijnen C.J. Cortisol and severe fatigue: a longitudinal study in adolescent girls. Psychoneuroendocrinology 2007, 32(2):171-182.
87. Thomas K.S., Motivala S., Olmstead R., Irwin M.R. Sleep depth and fatigue: role of cellular inflammatory activation. Brain Behav. Immun. 2011, 25:53-58.
88. Tomoda A., Joudoi T., Rabab E.M., Matsumoto T., Park T.H., Miike T. Cytokine production and modulation: comparison of patients with chronic fatigue syndrome and normal controls. Psychiatry Res. 2005, 134(1):101-104.
89. Torres-Harding S., Sorenson M., Jason L., Reynolds N., Brown M., Maher K., Fletcher M.A. The associations between basal salivary cortisol and illness symptomatology in chronic fatigue syndrome. J. Appl. Biobehav. Res. 2008, 13(3):157-180.
90. Trune D.R., Larrain B.E., Hausman F.A., Kempton J.B., MacArthur C.J. Simultaneous measurement of multiple ear proteins with multiplex ELISA assays. Hear. Res. 2011, 275:1-7.
91. Vollmer-Conna U., Fazou C., Cameron B., Li H., Brennan C., Luck L., Davenport T., Wakefield D., Hickie J., Lloyd A. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol. Med. 2004, 34:1289-1297.
92. Walker K., Lindner H., Noonan M. The role of coping in the relationship between depression and illness severity in Chronic Fatigue Syndrome. J. Allied Health 2009, 38(2):91-99.
93. White P.D., Goldsmith K.A., Johnson A.L., Potts L., Walwyn R., DeCesare J.C., Baber H.L., Burgess M., Clark L.V., Cox D.L., Bavinton J., Angus B.J., Murphy G., Murphy M., O'Dowd H., Wilks D., McCrone P., Chalder T., Sharpe M. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. The Lancet 2011, 377:823-836.
94. Wibourg J.F., Knoop H., Stulemeijer M., Prins J.B., Bleijenberg G. How does cognitive behaviour therapy reduce fatigue in patients with chronic fatigue syndrome? The role of physical activity. Psychol. Med. 2010, 40(8):1281-1287.
95. Willis C., Morris J.M., Danis V., Gallery E.D. Cytokine production by peripheral blood monocytes during the normal human ovulatory menstrual cycle. Hum. Reprod. 2003, 18:1173-1178.
96. Wong H.L., Pfeiffer R.M., Fears T.R., Vermeulen R., Ji S., Rabkin C.S. Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiol. Biomarkers Prev. 2008, 17:3450-3456.
97. Yehuda R., Teicher M.H., Trestman R.L., Levengood R.A., Siever L.J. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol. Psychiatry 1996, 40(2):79-88.